David B. Weiner - 11 Mar 2023 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Director
Signature
/s/ David B. Weiner
Issuer symbol
INO
Transactions as of
11 Mar 2023
Net transactions value
-$6,708
Form type
4
Filing time
13 Mar 2023, 17:10:11 UTC
Previous filing
28 Feb 2023
Next filing
16 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +11,666 +1.3% 915,957 11 Mar 2023 Direct F1
transaction INO Common Stock Sale $6,708 -5,833 -0.64% $1.15 910,124 13 Mar 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Options Exercise $0 -11,666 -100% $0.000000* 0 11 Mar 2023 Common Stock 11,666 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on March 11, 2021; 11,667 shares vested on March 11, 2022; and 11,666 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 13, 2022.